Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nukkleus (NUKK) Total Liabilities (2021 - 2025)

Historic Total Liabilities for Nukkleus (NUKK) over the last 5 years, with Q2 2025 value amounting to $60.5 million.

  • Nukkleus' Total Liabilities rose 35340.56% to $60.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $60.5 million, marking a year-over-year increase of 35340.56%. This contributed to the annual value of $8.1 million for FY2024, which is 1532.75% down from last year.
  • Nukkleus' Total Liabilities amounted to $60.5 million in Q2 2025, which was up 35340.56% from $65.8 million recorded in Q1 2025.
  • Over the past 5 years, Nukkleus' Total Liabilities peaked at $172.5 million during Q4 2024, and registered a low of $2.1 million during Q4 2021.
  • In the last 5 years, Nukkleus' Total Liabilities had a median value of $8.1 million in 2024 and averaged $25.6 million.
  • Data for Nukkleus' Total Liabilities shows a peak YoY increase of 129890.63% (in 2024) and a maximum YoY decrease of 1532.75% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Nukkleus' Total Liabilities stood at $2.1 million in 2021, then surged by 87.98% to $4.0 million in 2022, then skyrocketed by 210.03% to $12.3 million in 2023, then surged by 1298.91% to $172.5 million in 2024, then tumbled by 64.9% to $60.5 million in 2025.
  • Its Total Liabilities stands at $60.5 million for Q2 2025, versus $65.8 million for Q1 2025 and $172.5 million for Q4 2024.